Fidelity Quality Factor ETF (FQAL) Announces Dividend Increase – $0.14 Per Share

Share on StockTwits

Fidelity Quality Factor ETF (NYSEARCA:FQAL) announced a quarterly dividend on Friday, March 15th, Wall Street Journal reports. Stockholders of record on Monday, March 18th will be paid a dividend of 0.141 per share on Wednesday, March 20th. This represents a $0.56 annualized dividend and a dividend yield of 1.67%. The ex-dividend date of this dividend is Friday, March 15th. This is an increase from Fidelity Quality Factor ETF’s previous quarterly dividend of $0.13.

Shares of NYSEARCA:FQAL traded up $0.04 on Friday, hitting $33.71. The company had a trading volume of 6,919 shares, compared to its average volume of 28,632. Fidelity Quality Factor ETF has a 52-week low of $28.26 and a 52-week high of $35.05.

TRADEMARK VIOLATION WARNING: This report was posted by Zolmax and is the sole property of of Zolmax. If you are accessing this report on another domain, it was illegally stolen and reposted in violation of United States and international copyright & trademark law. The legal version of this report can be viewed at https://zolmax.com/investing/fidelity-quality-factor-etf-fqal-announces-dividend-increase-0-14-per-share/2965927.html.

See Also: Are all No-Load Funds Equal?

Dividend History for Fidelity Quality Factor ETF (NYSEARCA:FQAL)

Receive News & Ratings for Fidelity Quality Factor ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fidelity Quality Factor ETF and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Qualys  Cut to Hold at Summit Redstone
Qualys Cut to Hold at Summit Redstone
Contrasting Rex Energy  & Energen
Contrasting Rex Energy & Energen
$154.25 Million in Sales Expected for Tivity Health Inc  This Quarter
$154.25 Million in Sales Expected for Tivity Health Inc This Quarter
vTv Therapeutics  PT Set at $3.00 by Northland Securities
vTv Therapeutics PT Set at $3.00 by Northland Securities
Fluent  Cut to Sell at Zacks Investment Research
Fluent Cut to Sell at Zacks Investment Research
Critical Analysis: Millicom International Cellular  and Its Competitors
Critical Analysis: Millicom International Cellular and Its Competitors


Leave a Reply

 
© 2006-2019 Zolmax.